As part of your daily routine as an active trader or investor, it's important to track the stocks in the market that are making the biggest percentage gains and the biggest percentage losses.

Stocks that are making large moves to the upside are favorites among short-term traders who want to capture some of that massive volatility. Stocks that are making big-percentage moves are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

Stocks that are in favor and making large moves is a segment of the market that I tweet about on a regular basis.These are also the exact type of stocks that I love to trade and alert to my subscribers in real-time.

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside.

Weatherford International

  • Thursday's Range: $5.31-$5.99
  • 52-Week Range: $4.71-$14.64
  • Thursday's Volume: 119.14 million
  • Three-Month Average Volume: 20.18 million

Weatherford International (WFT) - Get Report , together with its subsidiaries, operates as a multinational oilfield service company worldwide. This stock closed up 6.5% to $5.89 in Thursday's trading session.

From a technical perspective, Weatherford International ripped sharply higher on Thursday back above its 20-day moving average of $5.50 a share with monster upside volume flows. This stock has been uptrending a bit over the last few weeks, with shares moving higher off its new 52-week low of $4.71 a share to its intraday high on Thursday of $5.98 a share. During that uptrend, this stock has been making mostly higher lows and higher highs, which is bullish technical price action. This high-volume rip higher is now quickly pushing shares of Weatherford International within range of triggering a big breakout trade. That trade will trigger if this stock manages to take out some near-term overhead resistance at $6 a share with high volume.

Traders should now look for long-biased trades in Weatherford International as long as it's trending above some near-term support at $5.28 a share and then once it sustains a move or close above $6 a share with volume that hits near or above 20.18 million shares. If that breakout takes hold soon, then this stock will set up to re-test or possibly take out its next major overhead resistance level at its 50-day moving average of $6.79 a share. Any high-volume move above $6.79 will then give this stock a chance to re-fill some of its previous gap-down-day zone from May that started near $8 a share.

Epirus Biopharmaceuticals

  • Thursday's Range: $0.69-$0.78
  • 52-Week Range: $0.53-$8.75
  • Thursday's Volume: 1.16 million
  • Three-Month Average Volume: 215,109

Epirus Biopharmaceuticals (EPRS)  develops, manufactures and commercializes biosimilar therapeutics worldwide. This stock traded up 5.5% to 76 cents per share in Thursday's trading session.

From a technical perspective, EPIRUS Biopharmaceuticals spiked notably higher on Thursday with monster upside volume flows. This high-volume rip to the upside is now quickly pushing this stock within range of triggering a major breakout trade above some key near-term overhead resistance levels. That trade will trigger if shares of Epirus Biopharmaceuticals manages to take out some near-term overhead resistance levels at 80 to 85 cents per share with high volume.

Traders should now look for long-biased trades in Epirus Biopharmaceuticals as long as it's trending above some near-term support at 66 cents per share or above more support at 60 cents per share and then once it sustains a move or close above those breakout levels with volume that hits near or above 215,109 shares. If that breakout develops soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at its 20-day moving average of $1 a share or around $1.20 a share.

Cara Therapeutics

  • Thursday's Range: $6.14-$6.52
  • 52-Week Range: $4.26-$23.61
  • Thursday's Volume: 738,000
  • Three-Month Average Volume: 741,520

Cara Therapeutics (CARA) - Get Report , a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors in the U.S. This stock traded up 5% to $6.45 in Thursday's trading session.

From a technical perspective, Cara Therapeutics spiked sharply higher on Thursday right above some near-term support at $6.08 a share and back above its 50-day moving average of $6.33 a share with decent upside volume flows. This stock has been uptrending over the last few weeks, with shares moving higher off its low of $5.01 a share to its recent high of $6.68 a share. During that uptrend, shares of Cara Therapeutics have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed this stock within range of triggering a big breakout trade above some key near-tem overhead resistance levels. That trade will trigger if this stock manages to clear some near-term overhead resistance levels at $6.68 to $7 a share and then above more key resistance at $7.35 a share with high volume.

Traders should now look for long-biased trades in Cara Therapeutics as long as it's trending above some near-term support at $6.08 a share or above its 20-day moving average of $5.83 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 741,520 shares. If that breakout kicks off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $8 to $8.50, or even $9 a share.

Roka Bioscience

  • Thursday's Range: $0.64-$0.67
  • 52-Week Range: $0.50-$3.75
  • Thursday's Volume: 78,000
  • Three-Month Average Volume: 48,488

Roka Bioscience (ROKA) , a molecular diagnostics company, focuses on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens in the U.S. This stock traded up 5% to 66 cents per share in Thursday's trading session.

From a technical perspective, Roka Bioscience spiked notably higher on Thursday right off its 50-day moving average of 64 cents per share with above-average volume. This high-volume trend to the upside is now quickly pushing shares of Roka Biosciences within range of triggering a big breakout trade above some key near-term overhead resistance levels. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at 70 to 75 cents per share and then above more key resistance at 80 cents per share with high volume.

Traders should now look for long-biased trades in Roka Bioscience as long as it's trending above its 20-day moving average of 61 cents per share or above more near-term support levels at 60 to 55 cents per share and then once it sustains a move or close above those breakout levels with volume that hits near or above 48,488 shares. If that breakout fires off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at 95 to $1, or even $1.10 to its 200-day moving average of $1.26 a share.

Affimed 

  • Thursday's Range: $3.44-$3.72
  • 52-Week Range: $2.76-$24.20
  • Thursday's Volume: 112,000
  • Three-Month Average Volume: 209,925

Affimed (AFMD) - Get Report , a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies. This stock traded up 5.4% to $3.69 in Thursday's trading session.

From a technical perspective, Affimed ripped sharply higher on Thursday right off its 20-day moving average of $3.45 a share with lighter-than-average volume. This stock recently formed a double bottom chart pattern, after shares found some buying interest at $2.76 to $2.85 a share. Following that potential bottom, this stock has now started to uptrend back above its 20-day moving average. That uptrend is now quickly pushing shares of Affimed within range of triggering a near-term breakout trade. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $3.74 a share to its 50-day moving average of $3.88 a share with high volume.

Traders should now look for long-biased trades in Affimed as long as it's trending above its 20-day moving average of $3.45 a share or above more near-term support at $3.29 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 209,925 shares. If that breakout materializes soon, then this stock will set up to re-test or possibly take out is next major overhead resistance levels at $4.10 to $4.25, or even $4.50 to $5 a share.

Merrimack Pharmaceuticals

  • Thursday's Range: $6.70-$7.00
  • 52-Week Range: $5.02-$13.00
  • Thursday's Volume: 1.24 million
  • Three-Month Average Volume: 1.95 million

Merrimack Pharmaceuticals (MACK) - Get Report , a biopharmaceutical company, engages in discovering, developing and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer primarily in the U.S. This stock traded up 4% to $7.00 in Thursday's trading session.

From a technical perspective, Merrimack Pharmaceuticals ripped notably higher on Thursday right above its 20-day moving average of $6.57 a share with decent upside volume flows. This stock recently formed a double bottom chart pattern, after shares found some buying interest at $6.12 to $6.08 a share. Following that potential bottom, shares of Merrimack Pharmaceuticals have now moved back above its 20-day moving average, and it's quickly trending within range of triggering a near-term breakout trade. That trade will trigger if this stock manages to take out some near-term resistance levels at $7 to $7.03 a share with high volume.

Traders should now look for long-biased trades in Merrimack Pharmaceuticals as long as it's trending above its 20-day moving average of $6.57 a share or above those recent double bottom support levels and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.95 million shares. If that breakout develops soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at its 50-day moving average of $7.35 to $7.50, or even $7.74 to its 200-day moving average of $8.02 a share.

Staar Surgical

  • Thursday's Range: $5.37-$5.63
  • 52-Week Range: $4.98-$10.76
  • Thursday's Volume: 112,000
  • Three-Month Average Volume: 143,559

Staar Surgical (STAA) - Get Report , together with its subsidiaries, designs, develops, manufactures and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. This stock traded up 3.1% to $5.62 in Thursday's trading session.

From a technical perspective, Staar Surgical trended notably higher on Thursday right above some near-term support at $5.21 a share with lighter-than-average volume. This stock has been consolidating and trending sideways over the last few weeks, with shares moving between $4.98 a share on the downside and around $5.90 a share on the upside. This spike higher on Thursday is now quickly pushing shares of Staar Surgical within range of triggering a big breakout trade above some key near-term overhead resistance levels. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $5.70 to $5.73 a share and then above its 20-day moving average of $5.89 a share with high volume.

Traders should now look for long-biased trades in Staar Surgical as long as it's trending above Thursday's intraday low of $5.37 a share or above more near-term support at $5.21 a share and then once it sustains a move or close above those breakout levels with volume that registers near or above 143,559 shares. If that breakout triggers soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at its 50-day moving average of $6.91 to $7 a share.

Disclosure: This article is commentary by an independent contributor. At the time of publication, the author held no positions in the stocks mentioned.